1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Supratentorial Glioma Global Clinical Trials Review, H1, 2014

Supratentorial Glioma Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Supratentorial Glioma Global Clinical Trials Review, H1, 2014" provides data on the Supratentorial Glioma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Supratentorial Glioma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Supratentorial Glioma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Supratentorial Glioma Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Supratentorial Glioma 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Countries: Proportion of Supratentorial Glioma to Oncology Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by Phase 15
In Progress Trials by Phase 16
Clinical Trials by Trial Status 17
Clinical Trials by End Point Status 18
Subjects Recruited Over a Period of Time 19
Clinical Trials by Sponsor Type 20
Prominent Sponsors 21
Top Companies Participating in Supratentorial Glioma Therapeutics Clinical Trials 22
Prominent Drugs 23
Clinical Trial Profiles 24
Clinical Trial Overview of Top Companies 24
Insys Therapeutics, Inc. 24
Clinical Trial Overview of Insys Therapeutics, Inc. 24
Direct Therapeutics, Inc. 25
Clinical Trial Overview of Direct Therapeutics, Inc. 25
Clinical Trial Overview of Top Institutes / Government 26
National Cancer Institute 26
Clinical Trial Overview of National Cancer Institute 26
Kentuckiana Cancer Institute 27
Clinical Trial Overview of Kentuckiana Cancer Institute 27
National Taiwan University Hospital 28
Clinical Trial Overview of National Taiwan University Hospital 28
Radiation Therapy Oncology Group 29
Clinical Trial Overview of Radiation Therapy Oncology Group 29
Case Comprehensive Cancer Center 30
Clinical Trial Overview of Case Comprehensive Cancer Center 30
National Institute of Neurological Disorders and Stroke 31
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 31
Lawson Health Research Institute 32
Clinical Trial Overview of Lawson Health Research Institute 32
Duke University 33
Clinical Trial Overview of Duke University 33
Assistance Publique - Hopitaux de Paris 34
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 34
University of California, San Francisco 35
Clinical Trial Overview of University of California, San Francisco 35
Five Key Clinical Profiles 36
Appendix 81
Abbreviations 81
Definitions 81
Research Methodology 82
Secondary Research 82
About GlobalData 83
Contact Us 83
Disclaimer 83
Source 84

List of Tables
Supratentorial Glioma Therapeutics, Global, Clinical Trials by Region, 2014* 6
Supratentorial Glioma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Supratentorial Glioma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Supratentorial Glioma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Supratentorial Glioma Therapeutics Clinical Trials, Europe, Top Countries, 2014* 10
Supratentorial Glioma Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Proportion of Supratentorial Glioma to Oncology Clinical Trials, G7 Countries (%), 2014* 12
Supratentorial Glioma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Supratentorial Glioma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Supratentorial Glioma Therapeutics, Global, Clinical Trials by Phase, 2014* 15
Supratentorial Glioma Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 16
Supratentorial Glioma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 17
Supratentorial Glioma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 18
Supratentorial Glioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 19
Supratentorial Glioma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 20
Supratentorial Glioma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 21
Supratentorial Glioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 22
Supratentorial Glioma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 23
Supratentorial Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Insys Therapeutics, Inc., 2014* 24
Supratentorial Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Direct Therapeutics, Inc., 2014* 25
Supratentorial Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 26
Supratentorial Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kentuckiana Cancer Institute, 2014* 27
Supratentorial Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014* 28
Supratentorial Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Radiation Therapy Oncology Group, 2014* 29
Supratentorial Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2014* 30
Supratentorial Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014* 31
Supratentorial Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Lawson Health Research Institute, 2014* 32
Supratentorial Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2014* 33
Supratentorial Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 34
Supratentorial Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014* 35

List of Figures
Supratentorial Glioma Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Supratentorial Glioma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Supratentorial Glioma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Supratentorial Glioma Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Supratentorial Glioma to Oncology Clinical Trials, G7 Countries (%), 2014* 12
Supratentorial Glioma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Supratentorial Glioma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Supratentorial Glioma Therapeutics, Global, Clinical Trials by Phase (%), 2014* 15
Supratentorial Glioma Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 16
Supratentorial Glioma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 17
Supratentorial Glioma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 18
Supratentorial Glioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 19
Supratentorial Glioma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 20
Supratentorial Glioma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 21
Supratentorial Glioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 22
Supratentorial Glioma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 23
GlobalData Methodology 82

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Hematological Cancers: Analytical Tool

Hematological Cancers: Analytical Tool

  • $ 11505
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation Summary Glioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is ...

Lung Cancer: Analytical Tool

Lung Cancer: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Ovarian Cancer: Analytical Tool

August 2016 $ 8096

Renal Cancer: Analytical Tool

August 2016 $ 8096

Bladder Cancer: Analytical Tool

August 2016 $ 8096

Brain Cancer: Analytical Tool

August 2016 $ 8096

Breast Cancer: Analytical Tool

August 2016 $ 8096

Download Unlimited Documents from Trusted Public Sources

Therapy and Hormone Market in South Korea

  • December 2016
    4 pages
  • Therapy  

    Hormone  

    Cancer  

  • South Korea  

View report >

Cancer Statistics in the UK

  • December 2016
    20 pages
  • Cancer  

  • United Kingdom  

    Europe  

View report >

Cancer Statistics in the US

  • December 2016
    112 pages
  • Cancer  

  • United States  

    North America  

View report >

Related Market Segments :

Cancer
Lymphoma
Therapy
Clinical Trial
Chemotherapy

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.